Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Gestodene Vaginal Ring
Product Overview
Alternative Name:
GES VR
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Vaginal Ring
Duration Type:
Long-acting
Description:
A vaginal ring, made of silastic and containing gestodene.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
gestodene
Inactive material:
Silastic
Potential Multi-Purpose Technology (MPT):
No
Duration:
1 year
Dose:
25 mg
Partner:
Shanghai Institute of Planned Parenthood Research (SIPPR)
,
Shanghai Dahua Pharmaceuticals, Ltd.
Status
Project Phase:
Early Development
Project Stage:
Pre-clinical
Began discovery in:
2007
Status Details:
All preclinical research work has been finished. Once approval is granted by SFDA (China), the clinical trial will start.
Programmatic Considerations
Additional Information
Download Product Report
